<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04551937</url>
  </required_header>
  <id_info>
    <org_study_id>16840</org_study_id>
    <nct_id>NCT04551937</nct_id>
  </id_info>
  <brief_title>Effects of Prebiotics on Cognition and Health</brief_title>
  <acronym>EPOCH-2</acronym>
  <official_title>The Effects of Prebiotics on Behavioral and Biological Markers of Cognition and Stress</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Urbana-Champaign</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Illinois at Urbana-Champaign</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research intervention aims to examine the effects of prebiotic consumption on changes in&#xD;
      behavioral and biological measures of cognition and stress among adults.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evidence-based dietary strategies provide behavioral means benefiting physical and cognitive&#xD;
      function. Pertinent to the proposed work, dietary intake has been recently shown to have the&#xD;
      potential to directly influence the gut microbiota composition as well as brain function.&#xD;
      Specifically, the consumption of prebiotics or fibers metabolized by gut bacteria may also&#xD;
      play a role. These foods are readily available in the marketplace, however, their&#xD;
      implications for physical and cognitive function are not clear. Accordingly, the proposed&#xD;
      study aims to investigate effects of prebiotic beverage consumption on changes in behavioral&#xD;
      and biological measures of cognition and stress among adults.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 14, 2018</start_date>
  <completion_date type="Actual">September 18, 2018</completion_date>
  <primary_completion_date type="Actual">September 18, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Participants will pass through 2 arms, control and prebiotic, in a randomized, counterbalanced order.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Double blind (participant and investigative team)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Biological markers of stress</measure>
    <time_frame>4-5 weeks</time_frame>
    <description>Changes in 24-hour urinary cortisol, inflammatory markers (e.g. IL-6, CRP).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Behavioral markers of stress</measure>
    <time_frame>4-5 weeks</time_frame>
    <description>Change in reported questionnaire responses specific to depression, stress, and anxiety using the Depression, Anxiety, and Stress (DASS) Questionnaire.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal Microbiota composition</measure>
    <time_frame>4-5 weeks</time_frame>
    <description>Impact on bacterial genera abundances.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal microbiota beta-diversity</measure>
    <time_frame>4-5 weeks</time_frame>
    <description>Impact on beta-diversity measures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal Microbiota alpha-diversity</measure>
    <time_frame>4-5 weeks</time_frame>
    <description>Impact on alpha-diversity measures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>4-5 weeks</time_frame>
    <description>Computer tasks will be used to assess working memory, interference control, cognitive flexibility, and hippocampal function/relational memory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep</measure>
    <time_frame>4-5 weeks</time_frame>
    <description>The Pittsburg Sleep Quality Index (PSQI) will also be used to assess sleep, as will actigraphy.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Physiological Stress</condition>
  <condition>Cognitive Change</condition>
  <condition>Gastrointestinal Health</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>4-5 week period where participant will consume control beverage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prebiotic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4-5 week period where participant will consume the intervention beverage</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lactose Free 1% Milk</intervention_name>
    <description>8 oz of study beverage daily</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Control</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lactose Free 1% Milk + 10 g prebiotic</intervention_name>
    <description>8 oz of study beverage supplemented with 5 grams of fructooligosaccharide and 5 grams of galactooligosaccharide</description>
    <arm_group_label>Prebiotic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males and females&#xD;
&#xD;
          -  Between the ages of 25-45 years at the time of consent&#xD;
&#xD;
          -  BMI â‰¥18.5 kg/m2&#xD;
&#xD;
          -  Normal or corrected-to-normal vision based on the minimal 20/20 standard in order to&#xD;
             complete the cognitive task.&#xD;
&#xD;
          -  Ability to drop-off fecal sample within 15 minutes of defecation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current pregnancy or lactation&#xD;
&#xD;
          -  Tobacco use&#xD;
&#xD;
          -  Dairy allergy or intolerance&#xD;
&#xD;
          -  Prior diagnosis of metabolic and gastrointestinal disease (cardiovascular disease and&#xD;
             type 1 or type 2 diabetes, chronic constipation, diarrhea, Crohn's disease, celiac&#xD;
             disease, ulcerative colitis, irritable bowel syndrome, diverticulosis, stomach or&#xD;
             duodenal ulcers, hepatitis, HIV, cancer, etc.)&#xD;
&#xD;
          -  Prior diagnosis of cognitive or physical disability, including ADHD, severe asthma,&#xD;
             epilepsy, chronic kidney disease&#xD;
&#xD;
          -  Use of any anti-psychotic, anti-depressant, antianxiety, or ADD/ADHD medications&#xD;
&#xD;
          -  Use of medications that alter normal bowel function and metabolism (e.g., recent&#xD;
             antibiotic use, laxatives, enemas, anti-diarrheal agents, narcotics, antispasmodics,&#xD;
             diuretics, anticonvulsants).&#xD;
&#xD;
          -  Prior malabsorptive bariatric surgery (i.e. gastric bypass, sleeve gastrectomy) or&#xD;
             restrictive bariatric surgery (i.e. adjustable gastric band)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hannah Holscher, PhD, RD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Illinois</name>
      <address>
        <city>Urbana</city>
        <state>Illinois</state>
        <zip>61801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>July 6, 2018</study_first_submitted>
  <study_first_submitted_qc>September 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>September 9, 2020</last_update_submitted>
  <last_update_submitted_qc>September 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Illinois at Urbana-Champaign</investigator_affiliation>
    <investigator_full_name>Hannah Holscher</investigator_full_name>
    <investigator_title>Assistant Professor of Nutrition</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

